Cardinal Health, Inc. (CAH) key performance indicators and operating metrics (20 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Pharmaceutical and Specialty Solutions revenue | 58.82B | FY2026-Q4 |
| Pharmaceutical and Specialty Solutions segment profit | 645M | FY2026-Q4 |
| Non-generally accepted accounting principles operating earnings | 935M | FY2026-Q4 |
| Non-generally accepted accounting principles diluted earnings per share | 3.17 USD_per_share | FY2026-Q3 |
| Generic Medicines and Pharmaceutical Distribution revenue | 3.11B | FY2026-Q4 |
| Global Medical Products and Distribution segment profit | 25M | FY2026-Q3 |
| Solaris Health providers | 750.00 | FY2026-Q3 |
| Non Us revenue | 423M | FY2026-Q3 |
| US revenue | 60.54B | FY2026-Q3 |
| Other segment profit | 183M | FY2026-Q4 |
| Non-generally accepted accounting principles effective tax rate | 22.50 percent | FY2026-Q4 |
| Other revenue | 1.71B | FY2026-Q4 |
| Accelerated share repurchase program | 250M | FY2026-Q3 |
| Global Medical Products and Distribution segment profit margin | 4.80 percent | FY2026-Q4 |
Back to CAH overview · CAH earnings · CAH holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.